IGC Pharma (IGC) Other Accumulated Expenses (2011 - 2026)
IGC Pharma (IGC) reported Other Accumulated Expenses of $101000.0 for Q1 2026, down 13.68% year-over-year from $117000.0 in Q1 2025, and down 70.81% quarter-over-quarter from $346000.0 in Q4 2025.
IGC Pharma (IGC) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 13 years of Other Accumulated Expenses data on file, last reported at $101000.0 in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $101000.0, down 13.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $101000.0 (down 13.68% YoY), and the FY2026 annual result was $101000.0, down 13.68% from the prior year.
- Other Accumulated Expenses declined to $101000.0 in Q1 2026 per IGC's latest filing, from $346000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $419000.0 in Q1 2024 and troughed at $72000.0 in Q3 2024.
- A 4-year average of $189000.0 and a median of $146000.0 in 2025 frame the typical range for Other Accumulated Expenses.
- On a YoY basis, Other Accumulated Expenses climbed as much as 195.73% in 2025 and fell as far as 72.08% in 2025.
- A 4-year view of Other Accumulated Expenses shows it stood at $209000.0 in 2023, then plunged by 44.02% to $117000.0 in 2024, then surged by 195.73% to $346000.0 in 2025, then plunged by 70.81% to $101000.0 in 2026.
- Business Quant data shows IGC's Other Accumulated Expenses at $101000.0 in Q1 2026, $346000.0 in Q4 2025, and $146000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | IGC Pharma | 28.11 Mn | 27.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101,000.00 |
| Dec 31, 2025 | 346,000.00 |
| Sep 30, 2025 | 146,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | 117,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Sep 30, 2024 | 72,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 419,000.00 |
| Dec 31, 2023 | 209,000.00 |
| Mar 31, 2023 | 258,000.00 |
| Dec 31, 2020 | 16,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Sep 30, 2018 | 659,000.00 |
| Jun 30, 2018 | 426,199.00 |
| Mar 31, 2018 | 494,000.00 |
| Dec 31, 2017 | 474,101.00 |
| Sep 30, 2017 | 409,597.00 |
| Jun 30, 2017 | 407,169.00 |